These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2088662)

  • 1. C2 nomenclature statement.
    Hauptmann G; John I; Uring-Lambert B; Arnold D
    Complement Inflamm; 1990; 7(4-6):252-4. PubMed ID: 2088662
    [No Abstract]   [Full Text] [Related]  

  • 2. Nomenclature for human complement component C2. WHO-IUIS Nomenclature Sub-Committee.
    WHO—IUIS Nomenclature Sub-Committee
    Bull World Health Organ; 1992; 70(4):527-30. PubMed ID: 1394787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of human C2 detected by immunoblotting.
    Doxiadis G; Doxiadis I; Grosse-Wilde H
    Hum Genet; 1985; 70(4):355-8. PubMed ID: 3894211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nomenclature for human complement component C2. WHO-IUIS Nomenclature Sub-Committee.
    J Immunol Methods; 1993 Jul; 163(1):1-2. PubMed ID: 8335954
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural polymorphism of mouse complement C2 detected by microscale peptide mapping: linkage to H-2.
    Takahashi S; Fukuoka Y; Moriwaki K; Okuda T; Tachibana T; Natsuume-Sakai S; Takahashi M
    Immunogenetics; 1984; 19(6):493-501. PubMed ID: 6735447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C2 reference typing report.
    Jahn I; Uring-Lambert B; Arnold D; Clemenceau S; Hauptmann G
    Complement Inflamm; 1990; 7(4-6):175-82. PubMed ID: 2088655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the genetic polymorphism of human C2 (native protein and C2a fragment) by immunoblotting after polyacrylamide gel isoelectric focusing.
    Uring-Lambert B; Gas S; Goetz J; Mauff G; Goldmann SF; Frössler M; Bender K; Hauptmann G
    Complement; 1985; 2(4):185-92. PubMed ID: 3913568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous detection of allotypes in native and activated human C2 by isoelectric focusing and silver staining.
    Segurado OG; Arnaiz-Villena A
    J Immunol Methods; 1989 Feb; 117(1):9-15. PubMed ID: 2464040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K; Omoto K; Juji T; Itoh T
    Hum Genet; 1982; 62(1):86-8. PubMed ID: 6924917
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic polymorphism of the second component of human complement (C2) in Japanese.
    Tokunaga K; Omoto K; Araki C; Juji T
    Jinrui Idengaku Zasshi; 1980 Dec; 25(4):287-93. PubMed ID: 7206304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genetic polymorphism of the second component of human complement (C2) in the Han Nationality in Wuhan district of China].
    Tian YW; Zhao XZ
    Yi Chuan Xue Bao; 1989; 16(3):226-9. PubMed ID: 2698234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the second component of complement (C2) in Graves' disease.
    Noel EP; Sampson L; Pepper BM; Farid NR
    Hum Hered; 1980; 30(4):245-7. PubMed ID: 6893039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H-2 S region determined polymorphic variants of the C4, Slp, C2, and B complement proteins: a compilation.
    Atkinson JP; Karp DR; Seeskin EP; Killion CC; Rosa PA; Newell SL; Shreffler DC
    Immunogenetics; 1982; 16(6):617-23. PubMed ID: 6190740
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies of genetic polymorphism of complement C2, B and C6 in systemic lupus erythematosus].
    Yukiyama Y; Tokunaga K; Yoshida K; Miyamoto T
    Ryumachi; 1985 Sep; 25(4):274-7. PubMed ID: 4081907
    [No Abstract]   [Full Text] [Related]  

  • 15. The molecular genetics and polymorphism of C2 and factor B.
    Campbell RD
    Br Med Bull; 1987 Jan; 43(1):37-49. PubMed ID: 3315100
    [No Abstract]   [Full Text] [Related]  

  • 16. Statement on the nomenclature of human C6 polymorphism.
    Mauff G; Alper CA; Hobart M; Kühnl P; Kunstmann G; Meo T; Olving JH; Rittner C
    Immunobiology; 1980; 158(1-2):139-43. PubMed ID: 7203515
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression and purification methods for the production of recombinant human complement component C2.
    Norton AW; Martini PG; Cook LC; Alderucci S; Lundberg DM; Fish SM; Bedard C; Gill J; Tzianabos AO; Concino MF
    Methods Mol Biol; 2014; 1100():61-74. PubMed ID: 24218250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bf and C2 polymorphism in Japanese patients with juvenile onset diabetes mellitus: existence of a variant Bf allele.
    Tokunaga K; Omoto K; Maeda H; Juji T; Ishiba S; Maruyama H
    Tissue Antigens; 1981 Nov; 18(5):365-8. PubMed ID: 6920176
    [No Abstract]   [Full Text] [Related]  

  • 19. Genetic polymorphism of the second component of human complement (C2): presentation of a modified typing technique and data on C2 phenotype distribution, linkage genetics, and haplotype associations a Norwegian family material.
    Olaisen B; Teisberg P; Gedde-Dahl T; Thorsby E
    Hum Genet; 1978 Jun; 42(3):301-5. PubMed ID: 669711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of properdin factor B(Bf), the second component (C2), and the fourth component (C4) of complement in leprosy patients and healthy controls from Thailand.
    Greiner J; Weber FJ; Mauff G; Baur M
    Immunobiology; 1980; 158(1-2):134-8. PubMed ID: 6907169
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.